Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03220958 · ClinicalTrials.gov registry record · Phase 3
Metoclopramide for Post Traumatic Headache
A Phase 3 study of Post-Traumatic Headache, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT03220958: Completed Phase 3 study of Post-Traumatic Headache, sponsored by Montefiore Medical Center.
NCT03220958 is a Phase 3 study of Post-Traumatic Headache that has completed, run by Montefiore Medical Center. The registered enrollment target is 160 participants, roughly in line with the 159-participant average among 11 other Post-Traumatic Headache trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03220958, a Phase 3 study of Post-Traumatic Headache, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
Nearly 1.5 million patients present to US emergency departments annually following head trauma. Headache is a frequent symptom of victims of head trauma. The purpose of this study is to see if an intravenous medication called metoclopramide can improve the symptoms of patients with acute post-traumatic headache.
Primary Outcome
Improvement in this 0 to 10 verbal rating scale
Conditions Studied
Interventions
- DRUG Normal saline
- DRUG Diphenhydramine
- DRUG Metoclopramide
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2020-04-01 |
| Phase | Phase 3 |
What the finished NCT03220958 record still lists
NCT03220958 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 159-participant average among 11 other Post-Traumatic Headache trials with a reported enrollment target.
The record links to 1 condition, with Post-Traumatic Headache appearing as the primary indexed condition, and to 3 interventions - of which Normal saline is the first listed.
NCT03220958 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03220958 about?
NCT03220958 is a clinical study titled "Metoclopramide for Post Traumatic Headache". Nearly 1.5 million patients present to US emergency departments annually following head trauma. Headache is a frequent symptom of victims of head trauma. The purpose of this study is to see if an intravenous medication called metoclopramide can improve the symptoms of patients with acute post-trauma...
What is the current status of trial NCT03220958?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 160 participants. The study started on 2017-08-01. Estimated completion is 2020-04-01.
What conditions does trial NCT03220958 study?
This clinical trial studies the following conditions: Post-Traumatic Headache.
What interventions are being tested in trial NCT03220958?
The interventions under investigation include: Normal saline (DRUG), Diphenhydramine (DRUG), Metoclopramide (DRUG).
Who is sponsoring clinical trial NCT03220958?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03220958 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-Traumatic Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03220958's enrollment target sits among peer trials
160 6th of 11 higher than 6 of 11 other Post-Traumatic Headache trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post-Traumatic Headache trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms
RECRUITING · NA
-
Greater Occipital Nerve Blockade in Veterans With Post-concussion Headache: Sub-study 1
RECRUITING · Phase 1
-
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
RECRUITING · Phase 2
-
Multisite Advancement of Research on Chronic Posttraumatic Headache
RECRUITING · NA
-
Ketamine, SGB and Combination Treatment for TBI
RECRUITING · Phase 2
-
e-CBT DTx for Post Traumatic Headaches in Adults With History of TBI
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI